Sinopharm Group Co. Ltd. (SHTDY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.97
    0.00 (0.03%)
    At close: Oct 03, 2025, 3:58 PM
    11.97
    -0.03%
    After-hours: Oct 01, 2025, 08:00 PM EDT

    Sinopharm Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 575.82B 584.51B 590.35B 596.57B 446.72B 407.24B 533.4B 521.05B 501.77B
    Cost of Revenue
    		 532.74B 540.25B 543.16B 548.06B 397.67B 359.8B 488.28B 477B 458.1B
    Gross Profit
    		 43.09B 44.26B 47.18B 48.51B 49.05B 47.43B 45.12B 44.05B 43.67B
    Operating Income
    		 15.11B 16.19B 18.6B 20.21B 23.08B 22.76B 21.42B 20.98B 20.59B
    Interest Income
    		 n/a n/a -778.48M 526.21M 1.64B 1.81B 3.16B 3.15B 2.85B
    Pretax Income
    		 13.6B 14B 18.24B 19.51B 14.84B 13.98B 17.29B 17B 17.1B
    Net Income
    		 6.8B 7.05B 8.65B 9.05B 8.94B 8.53B 7.87B 7.76B 7.87B
    Selling & General & Admin
    		 25.69B 25.57B 25.47B 26.78B 21.5B 20.19B 24.28B 23.66B 23.65B
    Research & Development
    		 123.36M n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 2.16B 2.49B 3.46B 2.12B 129.94B 129.94B n/a n/a n/a
    Operating Expenses
    		 27.98B 28.07B 28.92B 28.3B 150.85B 149.93B 24.67B 23.89B 23.72B
    Interest Expense
    		 n/a n/a n/a n/a 1.27B 1.27B n/a n/a n/a
    Selling & Marketing Expenses
    		 16.52B 17.16B 17.52B 17.47B 13.23B 12.58B 15.61B 15.44B 15.49B
    Cost & Expenses
    		 560.72B 568.32B 570.62B 574.9B 428.53B 389.74B 512.96B 500.89B 481.82B
    Income Tax Expense
    		 3.75B 3.58B 4.23B 4.5B 3.41B 3.22B 4.03B 3.94B 3.78B
    Shares Outstanding (Basic)
    		 623.01M 622.62M 624.11M 623.36M 623.36M 623.75M 623.36M 624.13M 624.13M
    Shares Outstanding (Diluted)
    		 623.01M 622.62M 624.11M 623.36M 623.36M 623.75M 623.36M 624.13M 624.13M
    EPS (Basic)
    		 10.90 11.30 13.90 14.55 14.35 13.70 12.65 12.45 12.60
    EPS (Diluted)
    		 10.90 11.30 13.90 14.55 14.35 13.70 12.65 12.45 12.60
    EBITDA
    		 20.58B 20.17B 23.02B 24.4B 18.15B 17.79B 23.39B 22.9B 22.54B
    EBIT
    		 17.14B 17.82B 20.86B 22.32B 17.07B 16.75B 21.42B 20.98B 20.59B
    Depreciation & Amortization
    		 3.44B 2.36B 2.16B 2.09B -4.94B -4.97B 1.97B 1.91B 1.95B

    Add to Watchlist